Dr. Naifu Liu 刘乃富
Chief Physician
Gynecologic Oncology, Cancer Hospital of Shandong First Medical University (Shandong Cancer Hospital), Jinan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical, radiation, chemotherapy, and comprehensive treatment for gynecologic tumors.
Dr. Liu has worked in the Department of Gynecologic Oncology at Shandong Cancer Hospital since July 1994, progressing from resident to chief physician and department head. Dr. Liu performs major surgeries including radical hysterectomy and ovarian cancer cytoreduction. Research includes two provincial projects and three SCI papers.
Professional roles
- Chair, Gynecologic Oncology Branch, Shandong Obstetrics and Gynecology Alliance
- Vice Chair, Minimally Invasive Gynecologic Oncology Branch, Shandong Medical Doctor Association
- Standing Committee Member, Cervical Lesion Branch, China Medicine Education Association
- Member, Gynecologic Oncology Professional Committee, Chinese Society of Clinical Oncology (CSCO)
Name order: in Chinese the family name comes first (Liu Naifu). Papers usually list the name as Naifu Liu or Liu N.
Selected publications
29 papers on PubMed matched by name and affiliation; 7 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Mol Med, 2026 (senior author): [Retracted] Suppression of SIK1 by miR‑141 in human ovarian cancer cell lines and tissues. PubMed 41312747
- Int J Mol Med, 2025 (senior author): [Expression of Concern] Suppression of SIK1 by miR‑141 in human ovarian cancer cell lines and tissues. PubMed 40910229
- World J Clin Cases, 2023 (senior author): Epithelioid trophoblastic tumor of the lower uterine segment and cervical canal: A case report. PubMed 36818614
- Exp Cell Res, 2022 (senior author): LPCAT1 functions as an oncogene in cervical cancer through mediating JAK2/STAT3 signaling. PubMed 36122769
- Chin Med J (Engl), 2021 (senior author): Correlations between alterations of T-helper 17 cells and treatment efficacy after concurrent radiochemotherapy in locally advanced cervical cancer (stage IIB-IIIB): a 3-year prospective study. PubMed 33840740
- Exp Ther Med, 2018 (senior author): L1CAM promotes epithelial to mesenchymal transition and formation of cancer initiating cells in human endometrial cancer. PubMed 29456682
- Int J Mol Med, 2016 (senior author): Suppression of SIK1 by miR-141 in human ovarian cancer cell lines and tissues. PubMed 27081781
- Oncol Lett, 2015 (senior author): A 10-gene expression signature of Notch pathway predicts recurrence in ovarian carcinoma. PubMed 26622736
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion